Broad Stem Cell Research Center

Broad Stem Cell Research Center
Name	Broad Stem Cell Research Center
Established	2005
Parent	University of California, Los Angeles
Director	Thomas Rando
Field	Stem cell research, Regenerative medicine
Location	Los Angeles, California

Broad Stem Cell Research Center. A premier interdisciplinary research hub at the University of California, Los Angeles dedicated to advancing fundamental and translational stem cell science. Established through a transformative gift from philanthropists Eli and Edythe Broad, the center brings together scientists and clinicians to pioneer new therapies for cancer, neurological disorders, and other intractable diseases. Its mission encompasses groundbreaking discovery, rigorous training, and the ethical application of regenerative medicine.

History and establishment

The center was formally launched in 2005 following a landmark $20 million donation from Eli and Edythe Broad, prominent philanthropists with a long history of supporting Los Angeles institutions like the Los Angeles County Museum of Art and The Broad museum. This founding gift was strategically aligned with the passage of California Proposition 71, which created the California Institute for Regenerative Medicine and provided significant state funding for stem cell research. Under the leadership of then-UCLA Chancellor Albert Carnesale and key faculty advocates, the center was established to consolidate and elevate the university's existing strengths in developmental biology and biomedical engineering. Its creation positioned UCLA as a central player in the burgeoning field of regenerative medicine, competing with other major research institutions such as the Stanford University School of Medicine and the University of California, San Francisco.

Research focus and programs

The center's research is organized around several core scientific programs aimed at translating basic discoveries into clinical applications. A major focus is on hematopoietic stem cell biology and the development of novel immunotherapies for cancers like leukemia and lymphoma. Another key program investigates pluripotent stem cells, including both embryonic stem cells and induced pluripotent stem cells, for modeling diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Research on tissue engineering and organoid development seeks to create functional tissues for repair and drug screening. The center also houses specialized initiatives like the UCLA Jonsson Comprehensive Cancer Center Stem Cell Program and training grants from the National Institutes of Health to educate the next generation of scientists.

Key discoveries and contributions

Investigators have made seminal contributions to the field, including pioneering methods for generating induced pluripotent stem cells from human somatic cells, a technology foundational to personalized medicine. Researchers have developed advanced CAR-T and natural killer cell therapies for treating aggressive cancers, leading to several FDA-approved clinical trials. Work on spinal cord injury has demonstrated the potential of neural stem cell transplantation to restore function in preclinical models. The center's scientists were also among the first to derive disease-specific pluripotent stem cell lines for conditions like Huntington's disease and retinitis pigmentosa, providing invaluable tools for understanding disease mechanisms.

Facilities and resources

The center operates from state-of-the-art laboratories within the UCLA campus, primarily in the Terasaki Life Sciences Building and the California NanoSystems Institute at UCLA. Core facilities provide researchers with critical shared technologies, including advanced flow cytometry, confocal microscopy, and a high-throughput genomic sequencing unit. A dedicated Good Manufacturing Practice facility supports the translation of cell-based therapies from the bench to clinical trials, ensuring compliance with stringent FDA regulations. These resources are accessible to affiliated faculty from across the university, including the David Geffen School of Medicine at UCLA and the Henry Samueli School of Engineering and Applied Science.

Leadership and organization

The center is directed by Dr. Thomas Rando, a renowned expert in muscle stem cell biology and aging. It is overseen by a faculty executive committee comprising leaders from various departments, ensuring interdisciplinary integration. The scientific director and associate directors manage the daily research operations and strategic initiatives. An external advisory board, featuring eminent scientists from institutions like the Massachusetts Institute of Technology and the Salk Institute for Biological Studies, provides guidance on scientific direction and ethical considerations. The organizational structure fosters collaboration between basic scientists from the UCLA College of Letters and Science and clinician-researchers from the Ronald Reagan UCLA Medical Center.

Collaborations and partnerships

The center maintains extensive local and global partnerships to accelerate research. It is a founding member of the California Institute for Regenerative Medicine's Alpha Stem Cell Clinics network, a collaborative statewide effort to conduct clinical trials. Key academic collaborations exist with the University of California, San Diego, the University of Southern California, and international partners like the RIKEN Center for Developmental Biology in Japan. Strong ties with the UCLA Jonsson Comprehensive Cancer Center and the UCLA Institute for Society and Genetics facilitate translational and ethical research. Partnerships with biotechnology and pharmaceutical companies, often managed through the UCLA Technology Development Group, help move discoveries toward commercialization and public benefit.

Category:University of California, Los Angeles Category:Stem cell research institutes Category:Medical and health organizations based in California Category:Research institutes established in 2005